Javascript er ikke aktivert i din nettleser. Dette er nødvendig for å bruke Oncolex. Kontakt din systemadministrator for å aktivere JavaScript.

Prognosis of skin cancer (non-melanoma)

Basal cell carcinoma

With modern treatment, basal cell carcinoma has a successful cure rate of over 90%, even if multiple treatment modalities must be applied. The problem, however is that new lesions in the skin have a tendency to develop over time requiring repeated treatments. This applies especially to hereditary forms and immunosuppressed patients.  

Squamous cell carcinoma

For squamous cell carcinoma, the prognosis is also good for localized disease, but the risk for lymphatic and hematogenous spreading is higher. With hematogenic spreading, the disease is in principle incurable.   



Five-year relative survival for patients with nonmelonoma skin cancer, in percent, during the diagnosis period 1974–2013.

Source: Cancer Registry of Norway


Oslo University Hospital shall not be liable for any loss whether direct, indirect, incidental or consequential, arising out of access to, use of, or reliance upon any of the content on this website. Oslo University Hospital© 2018